Nanosonics Ltd (ASX:NAN) receives European clearance for trophon2

Nanosonics Ltd (ASX:NAN) has received clearance for trophon2 from Europe

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Nanosonics Ltd (ASX: NAN) announced a pleasing piece of news this morning. The company said that trophon2 conforms with the European Union Requirements.

The trophon2 device is the second generation of the trophon system which prevents ultrasound probe cross-infection from occurring. Nanosonics boasts that the trophon device is easy to install, set-up and maintain, all it needs is to be plugged in.

Nanosonics now expects that trophon2 will be launched in Europe, the USA and Canada in the first quarter of the 2019 financial year. Its first-generation device has been popular with many thousands of devices being installed. It operates a "Gillette" model where the user buys the device and pays for high-margin consumables.

The CEO of Nanosonics, Michael Kavanagh, said "This is excellent news that enables Nanosonics to launch trophon2 for customers in both North America as well as Europe in the same time frame.

"The trophon2 delivers a range of exciting new customer focused features including new capabilities that were specifically developed based on feedback from the European market. The new trophon2 is currently being introduced into manufacturing and we look forward to bringing it to market in the first quarter of the 2019 financial year."

There are other products that Nanosonics is also researching and developing which could be launched over the next couple of years using the same sort of technology. These new devices could be just as big of an opportunity as trophon for Nanosonics.

Foolish takeaway

The products that Nansonics offers are excellent devices, but I find it hard to quantify what a reasonable valuation for the business would be. So for that reason, I am steering clear of Nanosonics shares. Although it could turn into a global healthcare leader in its space like Cochlear Limited (ASX: COH).

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »